| Line 389: | Line 389: | ||
*Acknowledgements: This work was supported by grants from the National Institutes of Health (NS42196 to J.R.P. and NS39828 to S.W.S.) and the Kentucky Tobacco Research and Development Center. We acknowledge the technical assistance of Melissa Yingling and Khaled Tanwir. | *Acknowledgements: This work was supported by grants from the National Institutes of Health (NS42196 to J.R.P. and NS39828 to S.W.S.) and the Kentucky Tobacco Research and Development Center. We acknowledge the technical assistance of Melissa Yingling and Khaled Tanwir. | ||
*KEYWORDS: nicotine; neurodegeneration; neuroprotection | *KEYWORDS: nicotine; neurodegeneration; neuroprotection | ||
='''Cancer / Cancer Treatments'''= | ='''Cancer / Cancer Treatments'''= | ||
edits